LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.51 | 17.25 | 1910 | 2906 | 0.6572 | 0.8897 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.48 | 17.25 | 1 | 3125 | 0.0003 | -0.3159 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.48 | 17.25 | 1427 | 3125 | 0.4565 | 0.8015 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.48 | 17.25 | 551 | 3125 | 0.1763 | 0.5869 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.48 | 17.25 | 2029 | 3125 | 0.6491 | 0.8880 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.45 | 17.25 | 1 | 3504 | 0.0003 | -0.3103 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.45 | 17.25 | 1500 | 3504 | 0.4281 | 0.7905 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.45 | 17.25 | 591 | 3504 | 0.1687 | 0.5856 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.45 | 17.25 | 2122 | 3504 | 0.6056 | 0.8733 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.42 | 17.25 | 1 | 3895 | 0.0003 | -0.3053 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.42 | 17.25 | 1590 | 3895 | 0.4081 | 0.7834 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.42 | 17.25 | 763 | 3895 | 0.1959 | 0.6236 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.42 | 17.25 | 2290 | 3895 | 0.5878 | 0.8686 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.39 | 17.25 | 1 | 4141 | 0.0002 | -0.3024 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.39 | 17.25 | 1712 | 4141 | 0.4134 | 0.7886 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.39 | 17.25 | 879 | 4141 | 0.2122 | 0.6440 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.39 | 17.25 | 2447 | 4141 | 0.5908 | 0.8712 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 48.36 | 17.25 | 2 | 4390 | 0.0005 | -0.2363 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 48.36 | 17.25 | 1779 | 4390 | 0.4052 | 0.7862 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 48.36 | 17.25 | 1050 | 4390 | 0.2392 | 0.6722 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 48.36 | 17.25 | 2594 | 4390 | 0.5908 | 0.8726 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.33 | 17.25 | 1 | 4651 | 0.0002 | -0.2972 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.33 | 17.25 | 1909 | 4651 | 0.4104 | 0.7912 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.33 | 17.25 | 1320 | 4651 | 0.2838 | 0.7112 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.33 | 17.25 | 2756 | 4651 | 0.5925 | 0.8745 | MN20160310_N02 | K11 |